Chemoinformaics analysis of (R)-4-Hydroxy-2,6,6-trimethyl-2-cyclohexene-1-one
Molecular Weight | 154.209 | nRot | 0 |
Heavy Atom Molecular Weight | 140.097 | nRig | 8 |
Exact Molecular Weight | 154.099 | nRing | 1 |
Solubility: LogS | -0.67 | nHRing | 0 |
Solubility: LogP | 0.921 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 25.9691 |
nHD | 1 | BPOL | 14.9129 |
QED | 0.531 |
Synth | 3.57 |
Natural Product Likeliness | 1.54 |
NR-PPAR-gamma | 0.782 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.04 |
Pgp-sub | 0.003 |
HIA | 0.007 |
CACO-2 | -4.562 |
MDCK | 0.0000334 |
BBB | 0.864 |
PPB | 0.44619 |
VDSS | 0.714 |
FU | 0.708918 |
CYP1A2-inh | 0.025 |
CYP1A2-sub | 0.595 |
CYP2c19-inh | 0.095 |
CYP2c19-sub | 0.844 |
CYP2c9-inh | 0.027 |
CYP2c9-sub | 0.726 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.742 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.26 |
CL | 10.192 |
T12 | 0.854 |
hERG | 0.006 |
Ames | 0.247 |
ROA | 0.117 |
SkinSen | 0.096 |
Carcinogencity | 0.189 |
EI | 0.539 |
Respiratory | 0.482 |
NR-Aromatase | 0.017 |
Antiviral | No |
Prediction | 0.92804 |